“Delveinsight Business Research LLP”

According to DelveInsight, the endometrial cancer therapeutics market is expected to grow in the coming years due to the increasing population of endometrial cancer patients in the 7MM and the expected launch of new therapies such as Kymriah, Yescarta and others.

DelveInsights “Endometrial Cancer Market Insights, Epidemiology and Market Forecast 2032The report provides an in-depth understanding of the disease, historical and forecast epidemiology, as well as market size, share and trends of Endometrial Cancer in the seven major markets (7MM) (i.e. United States, EU5 (Germany, Spain, Italy, France and United Kingdom ) and Japan).

The Endometrial Cancer market report covers new drugs, current treatment practices, market share of individual therapies, and current and forecast market size from 2019 to 2032. It also assesses current treatment practice/algorithm, key drivers and barriers impacting market growth, and unmet medical needs to curate the best opportunities and assess the underlying market potential.

Endometrial cancer: an overview

Endometrial cancer (a type of womb cancer) begins when cells in the endometrium start growing out of control. The most common type of endometrial cancer (type 1) is slow growing. It is most commonly found only in the uterus. Type 2 is rarer. It grows faster and tends to spread to other parts of the body. Some of the risk factors for endometrial cancer are: age, hormone levels, obesity, and genetics.

Key Data of Endometrial Cancer Market

• According to Cancer Research UK there are around 9,400 new cases of cervical cancer in the UK that’s 26 a day each year (2015-2017).

• According to the National Cancer Institute approximately 3 out of 100 women will be diagnosed with cervical cancer at some point in her life. More than 80 percent of people survive five years with cervical cancer or…